Bioanalytical Testing Services Market To Reach $11.2 Billion By 2033

Bioanalytical Testing Services Market Growth & Trends

The global bioanalytical testing services market size is expected to reach USD 11.2 billion by 2033, registering a CAGR of 9.9% from 2026 to 2033, according to a new report by Grand View Research, Inc. An increasing rate of outsourcing R&D activities by several biopharmaceutical companies to streamline their core competencies is one of the major factors supporting the market growth. In addition, the outbreak of COVID-19 has further boosted demand for pharma-analytical testing services as the rapid surge in SARS-CoV-2 infection cases has significantly augmented the production of a larger batch of COVID-19 vaccines across the globe.

Furthermore, the growing demand for pharmaceutical products across the globe has resulted in a surge of pipeline drugs that require bioanalytical testing for development, thus augmenting the market growth. In addition, the market is expected to witness considerable growth over the forecast period owing to an increasing number of contract manufacturing companies expanding their development capacities across the globe. For instance, in September 2023, Cerba HealthCare announced the acquisition of CIRION BioPharma Research, a Canadian contract research laboratory, to expand its bioanalytical capabilities and reduce the time required for implementing intricate clinical trials.

Increasing awareness about product quality, environmental issues, and the safety of consumers are driving companies to outsource tests as a means to ensure that their products comply with the aforementioned aspects. This helps them build brand image and protects as well as enhances reputation. The U.S. FDA has conducted workshops to increase awareness regarding bioanalytical testing and related regulations.

Key operating companies are undertaking various strategic initiatives to strengthen their market presence. For instance, in August 2023, Pace Analytical Services announced the acquisition of Alpha Analytical, adding new capabilities such as advanced hydrocarbon analytical support along with expanded sediment & tissue testing. Moreover, in April 2022, Charles River Laboratories acquired Explora BioLabs, a prominent player in contract research services, for USD 295 million in cash. This has broadened the company’s operating capabilities in the market.

 Request a free sample copy or view report summary: Bioanalytical Testing Services Market Report

Bioanalytical Testing Services Market Report Highlights

• The bioanalytical testing services industry is driven by technological advancements & growing R&D investments, stricter regulatory controls, increasing awareness of bioanalytical testing, and the expansion of bioanalytical testing facilities

• Furthermore, increasing awareness among stakeholders regarding the critical role of bioanalytical testing in ensuring drug safety, efficacy, and quality has fueled demand for these services

• Regulatory bodies such as the U.S. FDA and the EMA have implemented rigorous standards to ensure the safety, efficacy, and quality of pharmaceuticals and biologics

• The bioanalytical testing services industry is experiencing new growth opportunities, driven by the increased complexity of biologics, biosimilars, and advanced therapeutic products.

• In addition, the high number of drug development programs in clinical phases, ranging from Phase I to Phase III, provides opportunities for outsourced bioanalytical services.

• The U.S. tariffs on laboratory tools and equipment, including reagents and analytical equipment, are affecting the cost structure of the global market by increasing input costs from purchasing technologies abroad.

• The small molecule segment led the market with the largest revenue share of 55.1% in 2025. Small molecules have been the key factor in pharmaceutical development due to their extensive pharmacokinetics and established manufacturing processes

• The sample analysis segment accounted for the largest market revenue share in 2025. The segment’s growth is driven by increasing demand for accurate pharmacokinetic and pharmacodynamic data, rising clinical trial activity, and the development of complex biologics and personalized medicines

• North America dominated the global bioanalytical testing services market with the largest revenue share of 47.4% in 2025. The growth in the region is mainly driven by rising demand for biopharmaceuticals, ongoing technological advancements, and increased investment in R&D for new drugs.

Bioanalytical Testing Services Market Segmentation

Grand View Research has segmented the global bioanalytical testing services market based on molecule, test, workflow, application, end use, and region:

Bioanalytical Testing Services Molecule Outlook (Revenue, USD Million, 2021 - 2033)

• Small Molecule

• Large Molecule

  • LC-MS Studies

  • Immunoassays

    • Pharmacokinetics (PK)

    • ADA Assay

    • Other

  • Other Large Molecule Tests

Bioanalytical Testing Services Test Outlook (Revenue, USD Million, 2021 - 2033)

• ADME

  • In-vivo

  • In-vitro

• Pharmacokinetics (PK)

• Pharmacodynamics (PD)

• Bioavailability

• Bioequivalence

• Biomarker Testing

• Cell-based Assay

• Virology Testing

• Other Tests

Bioanalytical Testing Services Workflow Outlook (Revenue, USD Million, 2021 - 2033)

• Sample Collection and Preparation

  • Sample Collection, Handling, and Storage

  • Protein Precipitation

  • Liquid-Liquid Extraction

  • Solid Phase Extraction

  • Others

• Method Development and Validation

  • Sample Analysis

  • Hyphenated technique

  • Chromatographic technique

  • Electrophoresis

  • Ligand Binding Assay

  • Mass Spectrometry

  • Spectroscopic Techniques

    • Nuclear Magnetic Resonance (NMR)

    • Others

  • Genomic and Molecular Techniques

    • Polymerase Chain Reaction (PCR)

    • Next-Generation Sequencing (NGS)

    • Others

• Other processes

Bioanalytical Testing Services End Use Outlook (Revenue, USD Million, 2021 - 2033)

• Pharma & BioPharma Companies

• CDMO

• CRO

• Others

Bioanalytical Testing Services Regional Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • UAE

  • Saudi Arabia

  • Kuwait

  • Qatar

  • Oman

List of Key Players in Bioanalytical Testing Services Market

• Thermo Fisher Scientific, Inc.

• ICON plc

• Charles River Laboratories

• Laboratory Corporation of America Holdings.

• IQVIA Inc.

• Syneos Health

• SGS SA

• Intertek Group Plc

• Pace Analytical Services, LLC

• Medpace Holdings, Inc.

• WuXi AppTec